The Latest Analyst Ratings for scPharmaceuticals
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for scPharmaceuticals (NASDAQ:SCPH) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, scPharmaceuticals has an average price target of $18.5, an increase of 42.31% from the previous average price target of $13.00.
July 19, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bullish analyst ratings and an increased price target suggest a positive outlook for scPharmaceuticals.
Analysts have given scPharmaceuticals bullish ratings in the last quarter, indicating a positive sentiment towards the stock. The average price target has also increased by 42.31% from the previous target, suggesting that analysts expect the stock price to rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100